Here are five insights:
1. NeuroVice’s mission is to develop devices that enhance the lives of those living with neurological disorders.
2. The company’s team is working to develop a prototype called P.A.T.I., which is an oral device designed to stop patients from biting their tongues or hyper-salivating during seizures.
3. The company is aiming to fundraise $20,000 to complete a final design of the prototype.
4. The company has raised about $2,000 at this time.
5. Ms. Sanders graduated from Durham, N.C.-based Duke University in 2015 with a master of arts in bioethics and science policy.
More articles on devices:
Following successful study, Intralink-Spine promotes Rejuve as low back pain cure — 5 things to know
Exactech sells spine assets to ChoiceSpine: 5 things to know
SeaSpine unveils Vu a∙POD Prime NanoMetalene System for full commercial launch — 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
